STOCK TITAN

Erasca to Present at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

SAN DIEGO, June 01, 2023 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that management will present at the investor conferences listed below. Management will also participate in one-on-one investor meetings.

Jefferies Healthcare Conference (June 7 – 9, 2023)
Location: Marriott Marquis, New York, NY
Format: Presentation
Date and Time: Wednesday, June 7, 1:00-1:25 PM EDT
Webcast: https://wsw.com/webcast/jeff281/eras/1846130

Goldman Sachs Global Healthcare Conference (June 12 – 15, 2023)
Location: Waldorf Astoria Monarch Beach Resort & Club, Dana Point, CA
Format: Fireside Chat
Date and Time: Monday, June 12, 3:20-3:55 PM PDT
Webcast: https://cc.webcasts.com/gold006

An archived replay of the events will be available for 30 days following the webcast at Erasca.com/events.

About Erasca
At Erasca, our name is our mission: To erase cancer. We are a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Our company was co-founded by leading pioneers in precision oncology and RAS targeting to create novel therapies and combination regimens designed to comprehensively shut down the RAS/MAPK pathway for the treatment of cancer. We have assembled what we believe to be the deepest RAS/MAPK pathway-focused pipeline in the industry. We believe our team’s capabilities and experience, further guided by our scientific advisory board which includes the world’s leading experts in the RAS/MAPK pathway, uniquely position us to achieve our bold mission of erasing cancer.

Contact:
Joyce Allaire
LifeSci Advisors, LLC
jallaire@lifesciadvisors.com

Source: Erasca, Inc.


Erasca Inc

NASDAQ:ERAS

ERAS Rankings

ERAS Latest News

ERAS Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
San Diego

About ERAS

our mission at erasca is embedded in our name: to erase cancer in patients by creating a new generation of oncology drugs that we hope will not just treat, but actually cure. energized by recent scientific discoveries and advances in drugging various biological drivers of cancer, we are committed to solving oncology’s hardest problems. we have assembled a proven team and joined forces with world-class collaborators who embrace our ambitious goals.